Sanofi

(NASDAQ:SNY)

Latest On Sanofi (SNY):

Date/Time Type Description Signal Details
2023-05-31 12:34 ESTNewsSanofi mulls pivotal trials for multiple sclerosis candidate after Phase 2 winN/A
2023-05-25 05:56 ESTDividendA dividend of $1.9 has been announced on Feb 15, 2023. It will be paid Jun 23, 2023 with an ex-dividend date of May 25, 2023.Neutral
2023-05-19 17:21 ESTNewsSobi's hemophilia A therapy gets review in EUN/A
2023-05-18 13:01 ESTNewsSupreme Court rules against Amgen in Repatha patent dispute with Sanofi/ RegeneronN/A
2023-05-02 16:16 ESTNewsEli Lilly, Sanofi to cap insulin prices at $35 per month for uninsured New YorkersN/A
2023-05-01 15:39 ESTNewsSanofi stock rises on licensing deal with Maze for potential Pompe disease drugN/A
2023-05-01 15:39 ESTNewsEledon stock rises ~10% after up to $185M financingN/A
2023-04-29 01:35 ESTNewsSanofi cut to to sell at Deutsche Bank on Q1 results, outlookN/A
2023-04-28 00:47 ESTNewsSanofi SA (SNY) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 12:04 ESTNewsSanofi reports mixed Q1 earnings; reaffirms FY23 outlookN/A
2023-04-27 12:04 ESTNewsSanofi Q1 profit climbs on Dupixent as drug on track for €10B this yearN/A
2023-04-27 12:03 ESTNewsSanofi completes Provention Bio acquisitionN/A
2023-04-26 11:33 ESTNewsProvention Bio gains after HSR waiting period for Sanofi deal expiredN/A
2023-04-18 03:55 ESTNewsSanofi: The Growth Engine Is Slowly Picking Up SteamN/A
2023-04-17 14:25 ESTNewsSupreme Court turns down Sanofi bid to revive EpiPen lawsuit against ViatrisN/A
2023-04-14 18:49 ESTNewsGhana 1st in world to approve new malaria vaccine by OxfordN/A
2023-04-11 05:39 ESTNewsSanofi withdraws and refiles pre-merger notification, report form to acquire Provention BioN/A
2023-04-05 14:49 ESTNewsSanofi, BARDA break ground on new flu vaccine facility at Pennsylvania siteN/A
2023-04-04 05:38 ESTNewsLancet highlights potential of Sanofi's troubled hemophilia drug fitusiranN/A
2023-03-31 12:40 ESTNewsSanofi plans to spin-off consumer business in India - reportN/A
2023-03-29 20:30 ESTNewsRegeneron Libtayo gets expanded approval in EU for lung cancer subtypeN/A
2023-03-27 22:52 ESTNewsSupreme Court hears arguments in Amgen Repatha patent case against SanofiN/A
2023-03-23 10:15 ESTNewsSanofi stock rises as Dupixent shows benefit in lung disease smokers, meets phase 3 goalsN/A
2023-03-21 12:16 ESTNewsSanofi and Regeneron's Dupixent gets approval in EU to treat eczema in kids over 6 monthsN/A
2023-03-17 16:30 ESTNewsAcer stock slumps ~45% as ACER-801 paused after hot flashes trial disappoints; cash woesN/A
2023-03-17 01:31 ESTNewsSanofi cuts list price on Lantus insulin by 78% in the U.S.N/A
2023-03-13 05:53 ESTNewsProvention Bio stock rockets 260% on ~$2.9B acquisition by SanofiN/A
2023-03-07 11:58 ESTNewsFDA accepts for review Regeneron/Sanofi's Dupixent application for inflammatory skin conditionN/A
2023-03-02 08:59 ESTNewsSanofi's hemophilia A therapy Altuviiio meets main goal in trial, setting stage for EU filingN/A
2023-02-24 10:36 ESTNewsSanofi wins FDA nod for once-weekly bleeding disorder therapyN/A
2023-02-21 18:10 ESTNewsAstraZeneca, Sanofi BLA for nirsevimab for respiratory syncytial virus accepted by FDAN/A
2023-02-13 13:10 ESTNewsSanofi head of R&D to depart; eyes launch of 2 new drugs for hemophilia, RSV in 2023N/A
2023-02-04 03:26 ESTNewsSanofi SA (SNY) Q4 2022 Earnings Call TranscriptN/A
2023-02-04 03:25 ESTNewsSanofi: Increasing Our Long PositionN/A
2023-02-03 14:38 ESTNewsSanofi Non-GAAP EPS of €1.71 in-line, revenue of €10.72B misses by €260M; initiates FY23 guidanceN/A
2023-02-03 14:38 ESTNewsSanofi stock dips as Q4 revenue grows but vaccine sales fall; Dupixent drives moderate profit outlookN/A
2023-02-03 14:37 ESTNewsSanofi proposes annual dividend of €3.56N/A
2023-02-03 14:37 ESTNewsSanofi puts brakes on phase 3 trials of myasthenia gravis candidate tolebrutinibN/A
2023-02-02 11:19 ESTNewsSanofi Q4 2022 Earnings PreviewN/A
2023-01-31 21:57 ESTNewsHaleon said to evaluate potential deals to increase its size - reportN/A
2023-01-31 08:54 ESTNewsSanofi to lay off employees at 2 vaccine facilities in IndiaN/A
2023-01-30 07:36 ESTNewsSanofi, Regeneron Dupixent gets approval in EU for expanded use in eosinophilic esophagitisN/A
2023-01-27 15:07 ESTNewsSanofi, Regeneron Dupixent gets EMA panel nod to treat eczema in kids under 5N/A
2023-01-26 00:03 ESTNewsDenali to get $25M milestone as Sanofi begins dosing in multiple sclerosis studyN/A
2023-01-25 09:53 ESTNewsInnate, Sanofi licensing deal gets US antitrust clearanceN/A
2023-01-23 21:04 ESTNewsSanofi, CytoReason expanding collaboration to AI for inflammatory bowel disease targetsN/A
2023-01-13 15:49 ESTNewsJohnson & Johnson is scaling back COVID-19 vaccine production – WSJN/A
2023-01-11 04:11 ESTNewsSanofi SA (SNY) CEO Paul Hudson Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)N/A
2022-12-22 05:58 ESTNewsGSK, Sanofi COVID booster vaccine gets approval in UKN/A
2022-12-21 13:25 ESTNewsGlaxoSmithKline, Sanofi led European pharmas in stock performance in OctoberN/A

About Sanofi (SNY):

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY Quotes by TradingView

See Advanced Chart

General

  • Name Sanofi
  • Symbol SNY
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 99,412
  • Last Split Factor5:1
  • Last Split Date2013-09-30
  • Fiscal Year EndDecember
  • IPO Date2002-07-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.sanofi.com
View More

Valuation

  • Trailing PE 25.31
  • Forward PE 13.4
  • Price/Sales (Trailing 12 Mt.) 2.78
  • Price/Book (Most Recent Quarter) 1.63
  • Enterprise Value Revenue 3.54
  • Enterprise Value EBITDA 8.33
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $3.71
  • Next Year EPS Estimate $4.31
  • Profit Margin 33%
  • Return on Assets 4%
  • Return on Equity 20%
  • Earnings Per Share $1.94
  • Revenue Per Share $0
  • Gross Profit 25.27 billion
  • Quarterly Earnings Growth -2.8%
View More

Highlights

  • Market Capitalization 121.59 billion
  • PE Ratio 21.2
  • PEG Ratio 3.67
  • Analyst Target Price $64.67
  • Book Value Per Share $26.25
View More

Share Statistics

  • Shares Outstanding 2.5 billion
  • Shares Float 2.22 billion
  • % Held by Insiders <1%
  • % Held by Institutions 7.04%
  • Shares Short 5.41 million
  • Shares Short Prior Month 6.43 million
  • Short Ratio 1.51
View More

Technicals

  • Beta 0.35
  • 52 Week High $55
  • 52 Week Low $36.32
  • 50 Day Moving Average 47.28
  • 200 Day Moving Average 49.01
View More

Dividends

  • Forward Annual Dividend Rate $1.7
  • Forward Annual Dividend Yield 3.46%
  • Payout Ratio 51%
  • Dividend Date 2020-05-26
  • ExDividend Date 2020-04-30
  • Dividend Per Share $3.53
  • Dividend Yield 3.8%
View More

Sanofi (SNY) Dividend Calendar:

Sanofi pays an annual dividend of $1.7 per share, with a dividend yield of 3.8%.
SNY's last dividend payment was made to shareholders on May 26, 2020.
Sanofi pays out 51% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2023-05-252023-06-232023-05-262023-02-15$1.9
2022-05-042022-06-082022-05-052022-04-20$1.8
2022-05-042022-05-312022-05-052022-04-20$1.8
2021-05-032021-05-262021-05-042021-03-23$1.91
2020-04-302020-05-262020-05-012020-03-05$1.75
2019-05-072019-05-312019-05-08$1.72
2018-05-092018-06-042018-05-100000-00-00$1.79
2017-05-112017-06-072017-05-152017-02-16$1.64
2016-05-052016-06-012016-05-090000-00-00$1.66
2016-05-060000-00-002016-05-090000-00-00$1.66

Sanofi (SNY) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-05$9.74 billion$0.73$1.05-30.26%
2020-09-302020-10-29$N/A$1.08$1.034.82%
2020-06-302020-07-29$8.44 billion$0.75$0.6417.58%
2020-03-312020-04-24$N/A$0.88$0.827.62%
2019-12-312020-02-06$11.23 billion$0.74$0.696.86%
2019-09-302019-10-31$10.81 billion$1.07$1.043%
2019-06-302019-07-29$10.2 billion$0.73$0.721.46%
2019-03-312019-04-26$9.77 billion$0.79$0.772.38%
2018-12-312019-02-07$10.7 billion$0.63$0.67-6.53%
2018-09-302018-10-31$11.28 billion$1.04$1.003.9%
2018-06-302018-07-31$9.87 billion$0.73$0.721.25%
2017-12-312018-02-07$11.37 billion$0.65$1.04-37.19%
2017-09-302017-11-02$11.82 billion$1.00$0.963.34%
2017-06-302017-07-31$10.84 billion$0.80$0.764.51%
2017-03-312017-04-28$9.52 billion$0.77$0.7010.33%
2016-12-312017-02-08$7.93 billion$0.67$0.670.19%
2016-09-302016-10-28$10.78 billion$0.98$0.8021.95%
2016-06-302016-07-29$8.88 billion$0.73$0.721.79%
2016-03-312016-04-29$9.03 billion$0.77$0.77-0.84%
2015-12-312016-02-09$8.79 billion$0.75$0.714.85%
2015-09-302015-10-29$10.13 billion$0.90$0.882.27%
2015-06-302015-07-30$10.11 billion$0.55
2013-12-312014-02-06$12.38 billion$0.93$1.28-27.34%
2012-12-312013-02-07$12.32 billion$0.77$1.55-50.32%
2012-09-302012-10-25$12.22 billion$1.05$1.92-45.31%
2011-12-312012-02-08$10.33 billion$1.05$1.59-33.96%
2011-09-302011-11-03$10.51 billion$1.26$1.214.13%
2009-12-312010-02-10$10.39 billion$1.01$2.06-50.97%
2008-12-312009-02-11$10.03 billion$0.83$1.79-53.63%
2008-03-312008-04-30$11.41 billion$1.06$5.42-80.44%
2007-12-312008-02-12$11.39 billion$0.79$0.80-1.25%
2007-09-302007-10-31$11.44 billion$0.94$0.8510.59%
2007-06-302007-08-01$9.88 billion$0.84$0.89-5.62%
2007-03-312007-05-03$9.94 billion$1.03$0.8718.39%
2006-12-312007-02-13$11.13 billion$0.66$0.5911.86%
2006-09-302006-10-31$8.93 billion$0.80$0.7112.68%
2006-06-302006-08-02$9.98 billion$0.84$0.787.69%
2006-03-312006-05-05$8.89 billion$0.97$0.8810.23%
2005-12-312006-02-24$8.24 billion$0.64$0.631.59%
2005-09-302005-11-08$9.01 billion$0.88$0.7320.55%
2005-06-302005-08-31$7.88 billion$0.73$0.687.35%
2005-03-312005-05-13$8.64 billion$0.70$0.657.69%

Sanofi (SNY) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Sanofi (SNY) Chart:

Sanofi (SNY) News:

Below you will find a list of latest news for Sanofi (SNY) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sanofi (SNY) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17250CALL0 0372.66TRUE00
2024-05-1727.50CALL0 0321.83TRUE00
2024-05-17300CALL0 0170.55TRUE00
2024-05-1732.50CALL0 0106.51TRUE00
2024-05-17350CALL0 0100.5TRUE00
2024-05-1737.510.05CALL0 0201.06TRUE00
2024-05-17400CALL0 073.05TRUE00
2024-05-1742.50CALL0 060.46TRUE00
2024-05-17454.3CALL0 154112.23TRUE00
2024-05-1747.52.95CALL15 397635.59TRUE0.850.4
2024-05-17500.82CALL61 390721.05TRUE0.370.82
2024-05-1752.50.15CALL229 152122.04FALSE0.050.5
2024-05-17550.25CALL0 60FALSE00
2024-05-1757.50.24CALL0 470FALSE00
2024-05-17600CALL0 00FALSE00
2024-05-17650CALL0 00FALSE00
2024-05-17250PUT0 00FALSE00
2024-05-1727.50PUT0 00FALSE00
2024-05-17300PUT0 00FALSE00
2024-05-1732.50PUT0 00FALSE00
2024-05-17350PUT0 00FALSE00
2024-05-1737.50.05PUT0 80FALSE00
2024-05-17400.1PUT0 1080FALSE00
2024-05-1742.50.09PUT0 11648.91FALSE00
2024-05-17450.15PUT28 479138.03FALSE00
2024-05-1747.50.85PUT0 19665.74FALSE00
2024-05-17502.6PUT0 10147.46FALSE00
2024-05-1752.50PUT0 067.95TRUE00
2024-05-17557.1PUT0 1391.14TRUE00
2024-05-1757.59.62PUT0 20104.1TRUE00
2024-05-17600PUT0 0117.83TRUE00
2024-05-17650PUT0 0141.13TRUE00
2024-06-21250CALL0 0111.4TRUE00
2024-06-2127.50CALL0 0102.44TRUE00
2024-06-21300CALL0 085.15TRUE00
2024-06-2132.50CALL0 068.16TRUE00
2024-06-21350CALL0 062.71TRUE00
2024-06-2137.510CALL0 052.49TRUE00
2024-06-21400CALL0 047.44TRUE00
2024-06-2142.56.99CALL0 780.75TRUE00
2024-06-21454.49CALL0 17759.12TRUE00
2024-06-2147.52.9CALL21 176720.79TRUE2.90
2024-06-21501.1CALL16 118116.65TRUE1.10
2024-06-2152.50.4CALL0 117023.23FALSE00
2024-06-21550.2CALL10 141421.47FALSE0.20
2024-06-2157.50.05CALL0 2820FALSE00
2024-06-21600.35CALL0 220FALSE00
2024-06-2162.50.25CALL0 40FALSE00
2024-06-21650CALL0 00FALSE00
2024-06-21700.2CALL0 10FALSE00
2024-06-21750.1CALL0 20FALSE00
2024-06-21800CALL0 00FALSE00
2024-06-21250PUT0 00FALSE00
2024-06-2127.50.05PUT0 800FALSE00
2024-06-21300.05PUT0 270FALSE00
2024-06-2132.50.35PUT0 630FALSE00
2024-06-21350.18PUT0 7460.06FALSE00
2024-06-2137.50.1PUT0 1820FALSE00
2024-06-21400.11PUT0 43341.83FALSE00
2024-06-2142.50.53PUT0 40729.7FALSE00
2024-06-21450.4PUT2 86927.09FALSE-0.17-0.3
2024-06-2147.51.44PUT1 268528.91FALSE0.070.05
2024-06-21502.7PUT1 87331.76FALSE2.70
2024-06-2152.54.7PUT0 5338.71TRUE00
2024-06-21555PUT0 252.66TRUE00
2024-06-2157.510.2PUT0 3053.42TRUE00
2024-06-216012.5PUT0 2561.74TRUE00
2024-06-2162.516.5PUT0 569.38TRUE00
2024-06-21650PUT0 076.46TRUE00
2024-06-217024PUT0 5289.29TRUE00
2024-06-21750PUT0 097.54TRUE00
2024-06-21800PUT0 0109.97TRUE00
2024-09-20250CALL0 081.3TRUE00
2024-09-2027.50CALL0 065.36TRUE00
2024-09-203022CALL0 160.46TRUE00
2024-09-2032.50CALL0 052.45TRUE00
2024-09-20350CALL0 044.94TRUE00
2024-09-2037.512.15CALL0 137.84TRUE00
2024-09-20406.68CALL0 5232.42TRUE00
2024-09-2042.55.6CALL0 122.77TRUE00
2024-09-20453CALL0 3025.15TRUE00
2024-09-2047.51.8CALL0 12821.87TRUE00
2024-09-20502.15CALL0 49421.84TRUE00
2024-09-2052.51.25CALL0 20521.9FALSE00
2024-09-20550.8CALL11 84921.84FALSE0.80
2024-09-2057.50.18CALL0 110FALSE00
2024-09-20600.25CALL0 3621.79FALSE00
2024-09-20650CALL0 00FALSE00
2024-09-20700CALL0 00FALSE00
2024-09-20750CALL0 00FALSE00
2024-09-20250PUT0 00FALSE00
2024-09-2027.50PUT0 00FALSE00
2024-09-20300PUT0 00FALSE00
2024-09-2032.50PUT0 00FALSE00
2024-09-20350.3PUT0 60FALSE00
2024-09-2037.50.25PUT0 30FALSE00
2024-09-20400.73PUT0 7325.09FALSE00
2024-09-2042.50.75PUT0 50724.1FALSE00
2024-09-20451.15PUT0 13536.86FALSE00
2024-09-2047.53.23PUT0 23721.75FALSE00
2024-09-20503.8PUT0 1725.82FALSE00
2024-09-2052.58.8PUT0 219.11TRUE00
2024-09-20550PUT0 025.88TRUE00
2024-09-2057.59.1PUT0 1026.95TRUE00
2024-09-206011.9PUT0 533.17TRUE00
2024-09-20650PUT0 043.59TRUE00
2024-09-20700PUT0 050.48TRUE00
2024-09-20750PUT0 056.47TRUE00
2024-12-20250CALL0 067.93TRUE00
2024-12-2027.50CALL0 059.84TRUE00
2024-12-20300CALL0 055.72TRUE00
2024-12-2032.50CALL0 049.67TRUE00
2024-12-20350CALL0 068.55TRUE00
2024-12-2037.50CALL0 059.81TRUE00
2024-12-20400CALL0 038.26TRUE00
2024-12-2042.50CALL0 026.73TRUE00
2024-12-20450CALL0 029TRUE00
2024-12-2047.53.3CALL0 127.74TRUE00
2024-12-20503.15CALL0 14626.2TRUE00
2024-12-2052.52.5CALL1 1426.03FALSE2.50
2024-12-20550CALL0 023.61FALSE00
2024-12-2057.50CALL0 023.69FALSE00
2024-12-20600CALL0 024.12FALSE00
2024-12-20650CALL0 031.09FALSE00
2024-12-20700CALL0 00FALSE00
2024-12-20250PUT0 00FALSE00
2024-12-2027.50PUT0 00FALSE00
2024-12-20300PUT0 00FALSE00
2024-12-2032.50PUT0 00FALSE00
2024-12-20350PUT0 057.5FALSE00
2024-12-2037.50.55PUT0 300FALSE00
2024-12-20401.15PUT0 123.42FALSE00
2024-12-2042.51.15PUT0 319.96FALSE00
2024-12-20450PUT0 021.74FALSE00
2024-12-2047.54.23PUT0 320.67FALSE00
2024-12-20500PUT0 018.5FALSE00
2024-12-2052.50PUT0 016.78TRUE00
2024-12-20550PUT0 013.12TRUE00
2024-12-2057.50PUT0 014.32TRUE00
2024-12-20600PUT0 021.52TRUE00
2024-12-20650PUT0 029.23TRUE00
2024-12-20700PUT0 039.18TRUE00
2025-01-172023.8CALL0 484.27TRUE00
2025-01-17250CALL0 065.86TRUE00
2025-01-17280CALL0 060.02TRUE00
2025-01-173016.5CALL0 185.55TRUE00
2025-01-173316.32CALL0 052.79TRUE00
2025-01-173515CALL0 1065.91TRUE00
2025-01-17388.4CALL0 253.23TRUE00
2025-01-17407.89CALL0 19038.92TRUE00
2025-01-17427.5CALL0 426.02TRUE00
2025-01-17456.1CALL0 2630.59TRUE00
2025-01-17473.5CALL0 16729.33TRUE00
2025-01-17503.42CALL6 31225.02TRUE3.420
2025-01-1752.52.3CALL0 109725.48FALSE00
2025-01-17551.45CALL0 128324.98FALSE00
2025-01-1757.51.05CALL0 284524.36FALSE00
2025-01-17600.7CALL0 149924.32FALSE00
2025-01-1762.50.18CALL0 56124.77FALSE00
2025-01-17650.54CALL0 25224.28FALSE00
2025-01-17700.3CALL0 520FALSE00
2025-01-17750.1CALL0 700FALSE00
2025-01-17800.1CALL0 20FALSE00
2025-01-17850.1CALL0 150FALSE00
2025-01-17200.05PUT0 130FALSE00
2025-01-17250.1PUT0 250FALSE00
2025-01-17280.15PUT0 430FALSE00
2025-01-17300.18PUT0 2320FALSE00
2025-01-17330.36PUT0 2080FALSE00
2025-01-17350.35PUT0 376131.51FALSE00
2025-01-17380.55PUT0 39426.27FALSE00
2025-01-17400.8PUT0 46423.31FALSE00
2025-01-17421.15PUT0 40221.76FALSE00
2025-01-17451.75PUT0 35421.1FALSE00
2025-01-17472.5PUT0 70619.8FALSE00
2025-01-17504.1PUT0 23122.09FALSE00
2025-01-1752.55.44PUT0 26716.92TRUE00
2025-01-17557.4PUT0 26418.17TRUE00
2025-01-1757.510.6PUT0 14821.59TRUE00
2025-01-176012.7PUT0 8420.22TRUE00
2025-01-1762.515.1PUT0 1223.43TRUE00
2025-01-176517.9PUT0 026.49TRUE00
2025-01-177024.6PUT0 140.39TRUE00
2025-01-177522.6PUT0 040.24TRUE00
2025-01-17800PUT0 045.28TRUE00
2025-01-17850PUT0 050.4TRUE00

Latest SNY Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST90$49.945
Jun 13, 2022 7:59 PM EST32$49.945
Jun 13, 2022 7:59 PM EST100$49.92
Jun 13, 2022 7:59 PM EST1$49.94
Jun 13, 2022 7:59 PM EST5$49.93

Sanofi (SNY) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465920077215/0001104659-20-077215-index.htm
2019-12-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1121404/000000000019016674/0000000000-19-016674-index.htm
2020-01-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1121404/000000000020000685/0000000000-20-000685-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000021545719007294/0000215457-19-007294-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000083423720008778/0000834237-20-008778-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924319003822/0000899243-19-003822-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924319019809/0000899243-19-019809-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924319020073/0000899243-19-020073-index.htm
2020-07-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924320020277/0000899243-20-020277-index.htm
2020-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000089924320020587/0000899243-20-020587-index.htm
2019-06-2811-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465919038226/0001104659-19-038226-index.htm
2019-06-2811-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465919038230/0001104659-19-038230-index.htm
2020-05-26FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1121404/000110465920065593/0001104659-20-065593-index.htm
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465920077209/0001104659-20-077209-index.htm
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1121404/000110465920077215/0001104659-20-077215-index.htm
2020-03-0520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1121404/000112140420000006/0001121404-20-000006-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000112140420000015/0001121404-20-000015-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000112140420000017/0001121404-20-000017-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000112140420000020/0001121404-20-000020-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036119004808/0001140361-19-004808-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036119016600/0001140361-19-016600-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000114036119019468/0001140361-19-019468-index.htm
2019-12-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1121404/000114036119022193/0001140361-19-022193-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036120005506/0001140361-20-005506-index.htm
2020-03-1615-12BSecurities registration termination [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1121404/000114036120005872/0001140361-20-005872-index.htm
2020-03-1815-12B/ASecurities registration termination [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1121404/000114036120006142/0001140361-20-006142-index.htm
2020-05-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1121404/000114036120012717/0001140361-20-012717-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036120012718/0001140361-20-012718-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1121404/000114036120013625/0001140361-20-013625-index.htm
2020-06-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1121404/000114036120014084/0001140361-20-014084-index.htm
2019-02-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519026537/0001193125-19-026537-index.htm
2019-02-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519030709/0001193125-19-030709-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519033119/0001193125-19-033119-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519033125/0001193125-19-033125-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519033129/0001193125-19-033129-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519035454/0001193125-19-035454-index.htm
2019-02-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519041574/0001193125-19-041574-index.htm
2019-02-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519050684/0001193125-19-050684-index.htm
2019-03-0820-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1121404/000119312519068926/0001193125-19-068926-index.htm
2019-03-08IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1121404/000119312519068940/0001193125-19-068940-index.htm
2019-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519079140/0001193125-19-079140-index.htm
2019-04-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519124231/0001193125-19-124231-index.htm
2019-05-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519136912/0001193125-19-136912-index.htm
2019-05-22SDhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519153080/0001193125-19-153080-index.htm
2019-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519165623/0001193125-19-165623-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519167602/0001193125-19-167602-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519175326/0001193125-19-175326-index.htm
2019-07-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519194484/0001193125-19-194484-index.htm
2019-07-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519203054/0001193125-19-203054-index.htm
2019-07-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312519204925/0001193125-19-204925-index.htm
2019-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519204959/0001193125-19-204959-index.htm
2019-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519205456/0001193125-19-205456-index.htm
2019-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519217509/0001193125-19-217509-index.htm
2019-09-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519235767/0001193125-19-235767-index.htm
2019-10-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519267571/0001193125-19-267571-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519280117/0001193125-19-280117-index.htm
2019-12-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519309382/0001193125-19-309382-index.htm
2019-12-09SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519309390/0001193125-19-309390-index.htm
2019-12-10SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519309771/0001193125-19-309771-index.htm
2019-12-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519309976/0001193125-19-309976-index.htm
2019-12-11SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519310897/0001193125-19-310897-index.htm
2019-12-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312519310949/0001193125-19-310949-index.htm
2019-12-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1121404/000119312519324104/0001193125-19-324104-index.htm
2019-12-27SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312519324985/0001193125-19-324985-index.htm
2020-01-07SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520002606/0001193125-20-002606-index.htm
2020-01-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1121404/000119312520002611/0001193125-20-002611-index.htm
2020-01-09SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520004801/0001193125-20-004801-index.htm
2020-01-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1121404/000119312520006792/0001193125-20-006792-index.htm
2020-01-21SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520010588/0001193125-20-010588-index.htm
2020-01-23SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520012458/0001193125-20-012458-index.htm
2020-01-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520013048/0001193125-20-013048-index.htm
2020-02-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520022413/0001193125-20-022413-index.htm
2020-02-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520026621/0001193125-20-026621-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312520029094/0001193125-20-029094-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1121404/000119312520029096/0001193125-20-029096-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520047287/0001193125-20-047287-index.htm
2020-03-05IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1121404/000119312520063078/0001193125-20-063078-index.htm
2020-03-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520064704/0001193125-20-064704-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520090307/0001193125-20-090307-index.htm
2020-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520095260/0001193125-20-095260-index.htm
2020-04-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520100308/0001193125-20-100308-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520107771/0001193125-20-107771-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520111679/0001193125-20-111679-index.htm
2020-04-23SDhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520116451/0001193125-20-116451-index.htm
2020-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520121046/0001193125-20-121046-index.htm
2020-04-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520126294/0001193125-20-126294-index.htm
2020-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520135917/0001193125-20-135917-index.htm
2020-05-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1121404/000119312520140966/0001193125-20-140966-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520142604/0001193125-20-142604-index.htm
2020-05-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520149265/0001193125-20-149265-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520151283/0001193125-20-151283-index.htm
2020-05-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1121404/000119312520151324/0001193125-20-151324-index.htm
2020-05-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520152664/0001193125-20-152664-index.htm
2020-06-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520159251/0001193125-20-159251-index.htm
2020-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520162072/0001193125-20-162072-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520167522/0001193125-20-167522-index.htm
2020-06-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520171173/0001193125-20-171173-index.htm
2020-06-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520177538/0001193125-20-177538-index.htm
2020-07-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520188598/0001193125-20-188598-index.htm
2020-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520210507/0001193125-20-210507-index.htm
2020-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520212796/0001193125-20-212796-index.htm
2020-08-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520222513/0001193125-20-222513-index.htm
2020-08-18SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520222574/0001193125-20-222574-index.htm
2020-08-28SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520233611/0001193125-20-233611-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520240726/0001193125-20-240726-index.htm
2020-09-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520245105/0001193125-20-245105-index.htm
2020-09-14SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520245221/0001193125-20-245221-index.htm
2020-09-22SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520250596/0001193125-20-250596-index.htm
2020-09-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520251082/0001193125-20-251082-index.htm
2020-09-28SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1121404/000119312520255128/0001193125-20-255128-index.htm
2020-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520255624/0001193125-20-255624-index.htm
2020-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520261115/0001193125-20-261115-index.htm
2020-10-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520264582/0001193125-20-264582-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520271214/0001193125-20-271214-index.htm
2020-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520278007/0001193125-20-278007-index.htm
2020-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520282738/0001193125-20-282738-index.htm
2020-11-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1121404/000119312520285498/0001193125-20-285498-index.htm
2020-08-04F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1121404/000119380520000928/0001193805-20-000928-index.htm
2020-03-0425-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1121404/000135445720000106/0001354457-20-000106-index.htm

Sanofi (SNY) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sanofi (SNY). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 704%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-13 Sanofi10% Share HolderSell4,168,899.0037.66157,000,736.340.00https://www.sec.gov/Archives/edgar/data/1121404/000089924319003822/0000899243-19-003822-index.htm
2020-05-29 Sanofi10% Share HolderSell20,421,899.00509.8510,412,105,205.150.00https://www.sec.gov/Archives/edgar/data/1121404/000114036120012718/0001140361-20-012718-index.htm
2020-03-09 Sanofi10% Share HolderSell128,914.00489.6563,123,152.6220,421,899.00https://www.sec.gov/Archives/edgar/data/1121404/000114036120005506/0001140361-20-005506-index.htm
2019-09-10 Sanofi10% Share HolderSell172,904.00281.1548,611,803.9920,550,813.00https://www.sec.gov/Archives/edgar/data/1121404/000114036119016600/0001140361-19-016600-index.htm
2019-03-08 Sanofi10% Share HolderSell131,115.00412.1754,041,315.5420,723,717.00https://www.sec.gov/Archives/edgar/data/1121404/000114036119004808/0001140361-19-004808-index.htm
2020-06-09 Sanofi10% Share HolderSell120,234.00597.4871,837,410.32279,766.00https://www.sec.gov/Archives/edgar/data/1121404/000114036120013625/0001140361-20-013625-index.htm
2020-05-29 Sanofi10% Share HolderSell2,399,552.00509.851,223,411,587.20400,000.00https://www.sec.gov/Archives/edgar/data/1121404/000114036120012718/0001140361-20-012718-index.htm
2020-07-28 Sanofi10% Share HolderBuy81,250.0016.001,300,000.00520,125.00https://www.sec.gov/Archives/edgar/data/1121404/000089924320020587/0000899243-20-020587-index.htm
2019-07-22 Sanofi10% Share HolderBuy93,750.0016.001,500,000.00558,035.00https://www.sec.gov/Archives/edgar/data/1121404/000089924319020073/0000899243-19-020073-index.htm